文献速递肝病胰腺与胆道疾病

瑞典全国队列中1969至2016年间胆囊切除术后长期死亡率

Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-05-10

该研究将瑞典28个病理科胆囊组织病理报告与患者登记关联,纳入1969至2016年间159,946例20-79岁初次胆囊切除术成人,并按年龄和性别匹配5倍一般人群参照个体。中位随访12年,胆囊切除组总体死亡率校正风险比0.91(95%CI 0.90-0.92),20-39岁组死亡率较高,酒精相关病和吸烟相关病常见于该年龄段死亡者。

要点

  • 胆囊切除术后总体死亡率校正风险比0.91(95%CI 0.90-0.92),低于参照人群。
  • 20-39岁胆囊切除者死亡率2.1/1000人年 vs 参照1.4/1000人年,高于参照。
  • 50岁以上胆囊切除者总体和心血管死亡相对风险较低。

核心结论

  • 全国性瑞典队列中,较年轻年龄胆囊切除与较高长期死亡率相关,可能受较高酒精使用和吸烟影响。
  • 50岁以上个体中的反向关联可能反映被选择行胆囊切除者基础健康状况较好。

研究设计与样本

  • 将瑞典28个病理科胆囊组织病理报告与瑞典患者登记关联,识别1969至2016年间159,946例20-79岁初次胆囊切除术成人。
  • 每例患者按年龄和性别匹配5名一般人群参照个体(N=764,681)。
  • 采用Cox回归,风险比以匹配因素为条件,并额外校正2型糖尿病、肥胖、缺血性心脏病、慢性阻塞性肺疾病、酒精相关疾病和教育程度。

主要发现

  • 中位随访12年,胆囊切除参与者死亡38,401例(18.5/1000人年),参照个体死亡181,197例(18.4/1000人年)。
  • 总体死亡率校正风险比0.91(95%CI 0.90-0.92),心血管死亡率校正风险比0.85(95%CI 0.83-0.86),年龄间高度异质。
  • 20-39岁胆囊切除者绝对死亡率2.1/1000人年(95%CI 1.9-2.2) vs 参照1.4/1000人年(95%CI 1.3-1.4),高于参照。
  • 随访期间死亡的1015例20-39岁诊断患者中,酒精相关病占12.2%,吸烟相关疾病占7.4%。
  • 50岁以上胆囊切除者总体和心血管死亡相对风险较低;胆囊切除与癌症死亡无关(aHR 1.01;95%CI 0.99-1.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Few studies have reported overall and subgroup long-term survival after cholecystectomy. METHODS: Linking gallbladder histopathology reports from all of Sweden's 28 pathology departments to the Swedish Patient Register, we identified 159,946 adults 20-79 years of age with incident cholecystectomy between 1969 and 2016. Each patient was age- and sex- matched to 5 general population reference individuals (N = 764,681). Cox regression hazard ratios were conditioned on matching factors and additionally adjusted for type 2 diabetes, obesity, ischemic heart disease, chronic obstructive pulmonary disease, alcohol-related diseases, and education. RESULTS: During a median follow-up of 12 years, we identified 38,401 deaths (18.5 deaths per 1000 person-years [PY]) among cholecystectomy participants and 181,197 deaths in reference individuals (18.4 per 1000 PY). This corresponded to an adjusted hazard ratio (aHR) of 0.91 (95% confidence interval [CI], 0.90-0.92) for overall mortality, and low cardiovascular mortality (aHR, 0.85; 95% CI, 0.83-0.86), which highly heterogeneous by age. Cholecystectomy was associated with higher mortality in individuals 20-39 years of age, with absolute mortality rates of 2.1 (95% CI, 1.9-2.2) in cholecystectomy participants vs 1.4 (95% CI, 1.3-1.4) per 1000 PY in reference individuals. Alcohol-related disease (12.2%) and smoking-related disorders (7.4%) were common among the 1015 patients diagnosed at 20-39 years of age who died during follow-up. Individuals >50 years of age undergoing cholecystectomy had a lower relative risk of overall and cardiovascular mortality. Cholecystectomy was not associated with cancer mortality (aHR, 1.01; 95% CI, 0.99-1.03). CONCLUSIONS: In a nationwide, Swedish cohort, we observed that cholecystectomy at younger age was associated with higher long-term mortality, potentially influenced by higher alcohol use and smoking. The inverse association among individuals >50 years of age may reflect better underlying health of individuals selected for cholecystectomy.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Emilsson L, Joshi AD, Ludvigsson JF, et al. Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016. Clin Gastroenterol Hepatol. 2025. PMID: 40354909. doi:10.1016/j.cgh.2025.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。